Clinical trial
Effects of Losartan vs. Nebivolol vs. the Association of Both on the Progression of Aortic Root Dilation in Marfan Syndrome (MFS) With FBN1 Gene Mutations.
NCT00683124 is registered in ClinicalTrials.gov with Fondazione IRCCS Policlinico San Matteo di Pavia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Losartan vs. Nebivolol vs. the Association of Both on the Progression of Aortic Root Dilation in Marfan Syndrome (MFS) With FBN1 Gene Mutations.
- Lead sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- July 31, 2008
- Completion date
- July 31, 2013
- Enrollment
- 291 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.